Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing… Grant US-11896614-B2 United States of America 13 Feb 2024
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11851491-B2 United States of America 26 Dec 2023
Compositions and methods for immunooncology Grant US-11851659-B2 United States of America 26 Dec 2023
ENGINEERED FCRIIB SELECTIVE IGG1 FC VARIANTS AND USES THEREOF Application WO-2023239940-A1 World Intellectual Property Organisation (WIPO) 14 Dec 2023
T cell receptor-deficient T cell compositions Grant US-11834676-B2 United States of America 05 Dec 2023
Dosing regimen for GP100-specific TCR—anti-CD3 SCFV fusion protein Grant US-11827688-B2 United States of America 28 Nov 2023
CS1 targeted chimeric antigen receptor-modified T cells Grant US-11730797-B2 United States of America 22 Aug 2023
Human kynureninase enzymes and uses thereof Grant US-11648272-B2 United States of America 16 May 2023
Human kynureninase enzyme variants having improved pharmacological properties Grant US-11542486-B2 United States of America 03 Jan 2023
Nucleic acids encoding kynurenine depleting enzymes Grant US-11534463-B2 United States of America 27 Dec 2022
CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF Grant EP-2997141-B1 European Patent Office 12 Oct 2022
Therapeutic peptides that target TGF-beta interaction Grant US-11406665-B2 United States of America 09 Aug 2022
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11377638-B2 United States of America 05 Jul 2022
TOXICITY MANAGEMENT FOR ANTI-TUMOR ACTIVITY OF CARS Application EP-4019041-A1 European Patent Office 29 Jun 2022
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11242376-B2 United States of America 08 Feb 2022
CHIMERIC ANTIGEN RECEPTOR WITH A SPACER COMPRISING C2-SET IG-LIKE DOMAINS Application EP-3915578-A1 European Patent Office 01 Dec 2021
Administration of kynurenine depleting enzymes for tumor therapy Grant US-11168142-B2 United States of America 09 Nov 2021
T-cell receptor-deficient T cell compositions Grant US-11136549-B2 United States of America 05 Oct 2021
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11085021-B2 United States of America 10 Aug 2021
CD19 specific chimeric antigen receptor and uses thereof Grant US-11077144-B2 United States of America 03 Aug 2021
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11028142-B2 United States of America 08 Jun 2021
CD19 specific chimeric antigen receptor and uses thereof Grant US-11007224-B2 United States of America 18 May 2021
CD19 specific chimeric antigen receptor and uses thereof Grant US-10874693-B2 United States of America 29 Dec 2020
Methods for improving the efficacy and expansion of immune cells Grant US-10829735-B2 United States of America 10 Nov 2020
CS1 targeted chimeric antigen receptor-modified T cells Grant US-10821161-B2 United States of America 03 Nov 2020
CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF Application EA-036200-B1 Eurasian Patent Organisation 14 Oct 2020
Administration of kynurenine depleting enzymes for tumor therapy Grant US-10772913-B2 United States of America 15 Sep 2020
CRISPR-CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY Grant EP-3132030-B1 European Patent Office 26 Aug 2020
T cell receptor-deficient T cell compositions Grant US-10689618-B2 United States of America 23 Jun 2020
T-cell receptor-deficient T cell compositions Grant US-10689617-B1 United States of America 23 Jun 2020
T cell receptor-deficient T cell compositions Grant US-10689619-B2 United States of America 23 Jun 2020
T-cell receptor-deficient t cell compositions Grant US-10689616-B1 United States of America 23 Jun 2020
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10442849-B2 United States of America 15 Oct 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10358474-B2 United States of America 23 Jul 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10358473-B2 United States of America 23 Jul 2019
ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY Application EP-3492094-A1 European Patent Office 05 Jun 2019
Methods of making chimeric antigen receptor-expressing cells Grant US-10273300-B2 United States of America 30 Apr 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10208285-B2 United States of America 19 Feb 2019
TOXICITY MANAGEMENT FOR ANTI-TUMOR ACTIVITY OF CARS Application EP-3338794-A1 European Patent Office 27 Jun 2018
Administration of kynurenine depleting enzymes for tumor therapy Grant US-9975959-B2 United States of America 22 May 2018
T cell receptor-deficient T cell compositions Grant US-9957480-B2 United States of America 01 May 2018
T cell receptor-deficient T cell compositions Grant US-9938497-B2 United States of America 10 Apr 2018
Administration of kynurenine depleting enzymes for tumor therapy Grant US-9808486-B2 United States of America 07 Nov 2017
ENGINEERED ANTIBODY FC VARIANTS Application WO-2017040380-A2 World Intellectual Property Organisation (WIPO) 09 Mar 2017
AGENTS FOR REDUCING THE ACTIVITY OF GDF15 Application WO-2017013188-A1 World Intellectual Property Organisation (WIPO) 26 Jan 2017
METHODS FOR IMPROVING THE EFFICACY AND EXPANSION OF IMMUNE CELLS Application WO-2017015427-A1 World Intellectual Property Organisation (WIPO) 26 Jan 2017
ANTI-FIBULIN-3 ANTIBODIES AND USES THEREOF Application US-20170015757-A1 United States of America 19 Jan 2017
ENGINEERED IMMUNOGLOBULIN FC POLYPEPTIDES DISPLAYING IMPROVED COMPLEMENT ACTIVATION Application WO-2016130516-A1 World Intellectual Property Organisation (WIPO) 18 Aug 2016
TOXICITY MANAGEMENT FOR ANTI-TUMOR ACTIVITY OF CARS Application EP-2872171-A4 European Patent Office 10 Feb 2016
CRISPR-CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY Application WO-2015161276-A3 World Intellectual Property Organisation (WIPO) 10 Dec 2015
CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF Application WO-2014184143-A1 World Intellectual Property Organisation (WIPO) 20 Nov 2014